Business/press release/2026-09-24

OpenEvidence Valued at $15 Billion After New Funding Round

Healthcare AI company OpenEvidence, often described as 'ChatGPT for doctors,' has reportedly been valued at $15 billion following a new funding round. While multiple outlets confirm the valuation, one report also states the company raised $250 million and has quietly pivoted into drug development.

4 articles from 4 outlets covered this story. The underlying claim is sourced from a press release.

What do all outlets agree on?

4 outlets covered “OpenEvidence Valued at $15 Billion After New Funding Round”. All of them report the following:

  • OpenEvidence is a healthcare AI company
  • Described as 'ChatGPT for doctors'
  • Received a new funding round
  • Valued at $15 billion

Which outlets covered this?

All 4 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Which companies does this involve?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.